title: The current situation of treatment systems for alcoholism in Korea.
abstract: Alcoholism is becoming one of the most serious issues in Korea. The purpose of this review article was to understand the present status of the treatment system for alcoholism in Korea compared to the United States and to suggest its developmental direction in Korea. Current modalities of alcoholism treatment in Korea including withdrawal treatment, pharmacotherapy, and psychosocial treatment are available according to Korean evidence-based treatment guidelines. Benzodiazepines and supportive care including vitamin and nutritional support are mainly used to treat alcohol withdrawal in Korea. Naltrexone and acamprosate are the drugs of first choice to treat chronic alcoholism. Psychosocial treatment methods such as individual psychotherapy, group psychotherapy, family therapy, cognitive behavior therapy, cue exposure therapy, 12-step facilitation therapy, self-help group therapy, and community-based treatment have been carried out to treat chronic alcoholism in Korea. However, current alcohol treatment system in Korea is not integrative compared to that in the United States. To establish the treatment system, it is important to set up an independent governmental administration on alcohol abuse, to secure experts on alcoholism, and to conduct outpatient alcoholism treatment programs and facilities in an open system including some form of continuing care.
authors: Department of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
authors: Jee Wook
authors: JW
authors: Kim
authors: Boung Chul
authors: BC
authors: Lee
authors: Tae-Cheon
authors: TC
authors: Kang
authors: Ihn-Geun
authors: IG
authors: Choi
mesh_terms: D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000627:therapeutic use*; D000437:Alcoholism / Q000191:economics / Q000517:prevention & control / Q000628:therapy*; D001569:Benzodiazepines / Q000627:therapeutic use; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D011613:Psychotherapy; D056910:Republic of Korea; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000427:Alcohol Deterrents; D001569:Benzodiazepines; D013654:Taurine; D009271:Naltrexone; D000077443:Acamprosate
keywords: Alcoholism; Korea; Treatment system; United States
references: Psychopharmacology (Berl). 2009 Jan;201(4):611-8
references: 18795264
references: Eksp Klin Farmakol. 2000 May-Jun;63(3):70-3
references: 10934602
references: Alcohol Clin Exp Res. 2012 Apr;36(4):686-92
references: 21950637
references: Psychiatr Serv. 2005 Nov;56(11):1416-22
references: 16282261
references: J Nerv Ment Dis. 1977 Dec;165(6):387-94
references: 591937
references: JAMA. 2007 Oct 10;298(14):1641-51
references: 17925516
references: Lancet. 2007 Dec 8;370(9603):1915-22
references: 18068515
references: Pharmacol Biochem Behav. 2009 Jan;91(3):393-7
references: 18771681
references: J Prev Med Public Health. 2009 Nov;42(6):416-23
references: 20009489
references: J Clin Psychiatry. 2007 Nov;68(11):1691-700
references: 18052562
references: Alcohol Alcohol. 2000 Mar-Apr;35(2):202-9
references: 10787398
references: Clin Psychol Rev. 2003 Oct;23(5):639-63
references: 12971904
references: J Prev Med Public Health. 2006 Jan;39(1):21-9
references: 16613068
references: Addiction. 1997 Nov;92(11):1537-46
references: 9519495
references: J Clin Psychiatry. 1999 Jul;60(7):449-53
references: 10453799
references: Addiction. 1993 Mar;88(3):315-35
references: 8461850
references: Lancet. 2009 Jun 27;373(9682):2223-33
references: 19560604
references: Alcohol Clin Exp Res. 2012 Apr;36(4):654-62
references: 21919925
references: J Korean Med Sci. 2011 Jan;26(1):11-6
references: 21218023
references: J Clin Psychopharmacol. 2008 Feb;28(1):5-12
references: 18204334
references: Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41
references: 12634260